Charming Medical Limited MCTA

Annual Quarterly

FY2026 · ended Mar 31, 2026 · Revenue $2.62M · Filed Jul 30, 2026

Charming Medical Limited (MCTA) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $2.6 million and a net loss of $22,648. Free cash flow was -$1.6 million. As of Mar 31, 2026 it held $4.7 million in cash and investments and $1.1 million in total debt.

Revenue
$2.62M
Net income
$-22,648
Operating cash flow
$-1.22M
Free cash flow
$-1.56M
EPS
$0.00
Dividend per share
None
Shares outstanding
—
Net cash
$3.61M
FY 2026
Operating margin
-1.1%
FY 2026

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MCTA (Nasdaq)
Headquarters
Hong Kong, Hong Kong
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2035992

Other Services-Misc Health & Allied Services, NEC companies

All 15 Services-Misc Health & Allied Services, NEC companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2026
Mar 31, 2026
Revenue
$2.6M
Operating income
-$29,237
Net income
-$22,648
Diluted EPS
$0.00
Operating cash flow
-$1.2M
Free cash flow
-$1.6M
Total assets
$9.9M
Total liabilities
$4.7M
Stockholders' equity
$5.2M
Cash and investments
$4.7M
Total debt
$1.1M

Recent SEC filings

Form Description Filed Period
6-K Current report (foreign issuer) Sep 29, 2026 Sep 29, 2026
20-F Annual report (foreign issuer) Jul 30, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jul 21, 2026
6-K Current report (foreign issuer) May 6, 2026 May 6, 2026
6-K Current report (foreign issuer) Apr 2, 2026 Apr 2, 2026
6-K Current report (foreign issuer) Mar 31, 2026 Mar 31, 2026

All 37 Charming Medical Limited SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.